{"id":"mesenchymal-stem-cells","safety":{"commonSideEffects":[{"rate":null,"effect":"Infusion-related reactions"},{"rate":null,"effect":"Infection"},{"rate":null,"effect":"Immunogenicity"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"MSCs are multipotent stromal cells that can differentiate into various cell lineages (osteocytes, chondrocytes, adipocytes) to replace damaged tissue. They also secrete immunomodulatory cytokines and growth factors that reduce inflammation, promote angiogenesis, and suppress pathogenic immune responses, making them suitable for regenerative and immunological applications.","oneSentence":"Mesenchymal stem cells promote tissue repair and modulate immune responses through secretion of anti-inflammatory factors and differentiation into specialized cell types.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:20:57.942Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Graft-versus-host disease (GVHD)"},{"name":"Tissue repair and regeneration"},{"name":"Inflammatory conditions"}]},"trialDetails":[{"nctId":"NCT07498218","phase":"PHASE1","title":"Phase 1 Study of VELGRAFT, a Living Cellular Construct, in the Management of Chronic Diabetic Foot Ulcers Which Have Attained Granulation Tissue","status":"NOT_YET_RECRUITING","sponsor":"Ayu, Inc.","startDate":"2026-03-02","conditions":"Diabetic Foot Ulcer (DFU), Granulation of Chronic Diabetic Wounds","enrollment":24},{"nctId":"NCT06321198","phase":"NA","title":"A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD","status":"RECRUITING","sponsor":"Anhui Provincial Hospital","startDate":"2024-02-10","conditions":"Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD)","enrollment":12},{"nctId":"NCT06905834","phase":"PHASE2","title":"Evaluation of Allogenic Mesenchymal Stem Cell (MSC) Injection Therapy for Refractory Graft-versus-Host Disease (GVHD) Unresponsive to Conventional Treatments","status":"NOT_YET_RECRUITING","sponsor":"Instituto de Investigación Biomédica de Salamanca","startDate":"2026-05","conditions":"Dry Eye Disease (DED), Graft-Versus-Host Disease(GVHD)","enrollment":30},{"nctId":"NCT07495956","phase":"PHASE1, PHASE2","title":"cfMSC Therapy for Diabetes","status":"RECRUITING","sponsor":"Shenzhen Geno-Immune Medical Institute","startDate":"2026-03-16","conditions":"Type II Diabetes Mellitus","enrollment":30},{"nctId":"NCT07492966","phase":"","title":"Exosomes Effect on Visual Function in CVI","status":"COMPLETED","sponsor":"Hatice Semrin Timlioglu İper","startDate":"2024-06-30","conditions":"Cortical Visual Impairment, Visual Function","enrollment":32},{"nctId":"NCT07404709","phase":"PHASE1, PHASE2","title":"Study on the Safety and Efficacy of Intratympanic Injection of Small Extracellular Vesicles Derived From Mesenchymal Stem Cells in Severe and Profound Sudden Sensorineural Hearing Loss","status":"NOT_YET_RECRUITING","sponsor":"The Affiliated Hospital of Qingdao University","startDate":"2026-02-28","conditions":"Sudden Hearing Loss, Extracellular Vesicles","enrollment":9},{"nctId":"NCT07477600","phase":"PHASE1, PHASE2","title":"cfMSC Stem Cell Therapy Targeting COPD","status":"RECRUITING","sponsor":"Shenzhen Geno-Immune Medical Institute","startDate":"2026-03-10","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":30},{"nctId":"NCT06798623","phase":"PHASE1","title":"Anterior Cruciate Ligament (ACL) Reconstruction With Autologous Fat Pad Derived Mesenchymal Stem Cells","status":"RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2026-03-24","conditions":"Anterior Cruciate Ligament Reconstruction","enrollment":15},{"nctId":"NCT04476901","phase":"PHASE2","title":"Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy","status":"RECRUITING","sponsor":"Joshua M Hare","startDate":"2021-05-07","conditions":"Non-ischemic Dilated Cardiomyopathy","enrollment":136},{"nctId":"NCT02032004","phase":"PHASE3","title":"Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2014-03-03","conditions":"Chronic Heart Failure","enrollment":565},{"nctId":"NCT07487766","phase":"PHASE1, PHASE2","title":"The Safety and Efficacy of XytriX in the Treatment of Knee Osteoarthritis","status":"NOT_YET_RECRUITING","sponsor":"TricelX Inc.","startDate":"2026-05","conditions":"Osteoarthritis","enrollment":50},{"nctId":"NCT07487467","phase":"NA","title":"Autologous SVF Therapy for Type 2 Diabetes","status":"RECRUITING","sponsor":"Kaiser Clinic and Hospital","startDate":"2025-01-20","conditions":"Diabetes Mellitus, Type 2","enrollment":10},{"nctId":"NCT07339111","phase":"PHASE3","title":"Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis","status":"RECRUITING","sponsor":"Medipost, Inc.","startDate":"2026-03-11","conditions":"Knee Cartilage Defects","enrollment":300},{"nctId":"NCT07485751","phase":"EARLY_PHASE1","title":"Safety and Feasibility of Nasal Delivery of Human Dental Follicle Mesenchymal Stem Cell-Derived Exosomes for Negative Symptoms in Treatment-Resistant Schizophrenia: A Pilot Study","status":"NOT_YET_RECRUITING","sponsor":"Zigong Mental Health Center","startDate":"2026-03","conditions":"Schizophrenia Negative Type","enrollment":15},{"nctId":"NCT07479043","phase":"PHASE3","title":"To Evaluate the Safety and Potential Therapeutic Activity of JadiCell™, an Investigational Umbilical Cord-Derived Mesenchymal Stem Cell Therapy, in Patients Diagnosed With Acute Respiratory Distress Syndrome (ARDS).","status":"NOT_YET_RECRUITING","sponsor":"Breathe Biologics, Inc.","startDate":"2026-07","conditions":"Acute Respiratory Distress Syndrome","enrollment":128},{"nctId":"NCT07048314","phase":"PHASE1, PHASE2","title":"Stem Cells for Erectile Dysfunction Post RALP","status":"NOT_YET_RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2026-03-10","conditions":"Erectile Dysfunction, Prostate Cancer","enrollment":40},{"nctId":"NCT07480161","phase":"PHASE2, PHASE3","title":"Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile Dysfunction","status":"RECRUITING","sponsor":"Ankara City Hospital Bilkent","startDate":"2025-12-29","conditions":"Erectile Dysfunction With Diabetes Mellitus","enrollment":90},{"nctId":"NCT07474467","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Autologous Adipose-derived Mesenchymal Stem Cells Therapy in Adults With Atrophic Scars","status":"NOT_YET_RECRUITING","sponsor":"CellinCells","startDate":"2026-08-01","conditions":"Atrophic Scar","enrollment":31},{"nctId":"NCT07472270","phase":"PHASE1","title":"Safety Evaluation of MSC-based Therapy for Liver Cihcrosis Treatment","status":"NOT_YET_RECRUITING","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2026-03-15","conditions":"Liver Cirrhosis","enrollment":12},{"nctId":"NCT07471230","phase":"PHASE2","title":"Evaluation of Neuroinduced Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients With Parkinsonism","status":"NOT_YET_RECRUITING","sponsor":"Biocells Medical","startDate":"2026-11-23","conditions":"Parkinsonism or Parkinson's Disease Nos, Parkinsonism in Diseases Classified Elsewhere","enrollment":120},{"nctId":"NCT07471074","phase":"NA","title":"Phenotypic and Functional Study of Bone Marrow Mesenchymal Stem Cells in Waldenström Macroglobulinemia","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2026-02-10","conditions":"Waldenström Macroglobuloinemia","enrollment":50},{"nctId":"NCT04749667","phase":"PHASE1, PHASE2","title":"Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Haukeland University Hospital","startDate":"2021-08-09","conditions":"Multiple Sclerosis, Progressive Multiple Sclerosis","enrollment":18},{"nctId":"NCT07466953","phase":"PHASE3","title":"Objective Evaluation of Intradermal MSC-Derived Exosome Therapy on Facial Skin Quality","status":"NOT_YET_RECRUITING","sponsor":"Mert Ersan","startDate":"2026-04-01","conditions":"Skin Aging, Facial Aging, Skin Quality","enrollment":30},{"nctId":"NCT07467733","phase":"PHASE1, PHASE2","title":"Evaluation of the Safety and Preliminary Efficacy of Neuroinduced Mesenchymal Stem Cells and Exosome Therapy in Patients With Spinocerebellar Palsy","status":"NOT_YET_RECRUITING","sponsor":"Biocells Medical","startDate":"2026-06-01","conditions":"Spinocerebellar Ataxia - All Sub-types","enrollment":90},{"nctId":"NCT05651997","phase":"NA","title":"Study Comparing Two Methods for the Treatment of Large Chondral and Osteochondral Defects of the Knee","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire Vaudois","startDate":"2026-12","conditions":"Articular Cartilage Defect, Chondral Defect, Osteochondritis","enrollment":80},{"nctId":"NCT00543374","phase":"PHASE3","title":"Extended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's Disease","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2007-09-17","conditions":"Crohn's Disease","enrollment":98},{"nctId":"NCT00877903","phase":"PHASE2","title":"Prochymal® (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2009-03-30","conditions":"Myocardial Infarction","enrollment":220},{"nctId":"NCT00683722","phase":"PHASE2","title":"PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2008-03-20","conditions":"Pulmonary Disease, Chronic Obstructive, Pulmonary Emphysema, Chronic Bronchitis","enrollment":62},{"nctId":"NCT00482092","phase":"PHASE3","title":"Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's Disease","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2007-09-17","conditions":"Crohn's Disease","enrollment":330},{"nctId":"NCT01233960","phase":"PHASE3","title":"Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Disease","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2010-11-29","conditions":"Crohn's Disease","enrollment":73},{"nctId":"NCT00690066","phase":"PHASE2","title":"PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2008-06-11","conditions":"Type 1 Diabetes Mellitus, Type 1 Diabetes, Diabetes Mellitus, Insulin-Dependent","enrollment":63},{"nctId":"NCT07326059","phase":"","title":"Safety and Outcomes of MUSE Stem Cell Therapy in Individuals With Traumatic Brain Injury","status":"NOT_YET_RECRUITING","sponsor":"Healing Hope International","startDate":"2028-01","conditions":"Traumatic Brain Injury, Traumatic Brain Injury (TBI) Patients, Traumatic Brain Injury (TBI); Concussion, Initial Encounter","enrollment":10},{"nctId":"NCT04565665","phase":"PHASE1, PHASE2","title":"Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-07-29","conditions":"COVID-19 Infection, COVID-19-Associated Acute Respiratory Distress Syndrome, Hematopoietic and Lymphoid Cell Neoplasm","enrollment":70},{"nctId":"NCT06890494","phase":"EARLY_PHASE1","title":"Clinical Study on the Safety and Efficacy of BiTE-EV in Relapsed/Refractory Acute B-Cell Leukemia","status":"RECRUITING","sponsor":"Beijing GoBroad Hospital","startDate":"2025-01-18","conditions":"Leukemia","enrollment":3},{"nctId":"NCT07238062","phase":"","title":"\"An Intermediate Size Patient Population Expanded Access Protocol to Evaluate the Safety and Efficacy of Allogeneic HB-adMSCs (Hope Biosciences - Adipose Derived Mesenchymal Stem Cells) for the Treatment of Multiple System Atrophy.\"","status":"TEMPORARILY_NOT_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Multiple System Atrophy","enrollment":""},{"nctId":"NCT07457125","phase":"PHASE1, PHASE2","title":"The Effect of CB-Exo-A600 in Mild to Moderate Alzheimer's Disease","status":"NOT_YET_RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2026-03-10","conditions":"Mild to Moderate Alzheimer's Disease","enrollment":33},{"nctId":"NCT06915233","phase":"PHASE3","title":"A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle","status":"RECRUITING","sponsor":"Vericel Corporation","startDate":"2026-03","conditions":"Chondral Defect, Articular Cartilage Defect","enrollment":309},{"nctId":"NCT07452822","phase":"PHASE1, PHASE2","title":"Safety and Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells in Preventing Arteriovenous Fistula Stenosis in Patients With End-Stage Diabetic Kidney Disease","status":"NOT_YET_RECRUITING","sponsor":"Jiangsu Topcel-KH Pharmaceutical Co., Ltd.","startDate":"2026-02-20","conditions":"Arteriovenous Fistula Stenosis","enrollment":54},{"nctId":"NCT03896568","phase":"PHASE1","title":"MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2019-02-12","conditions":"IDH1 wt Allele, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma","enrollment":36},{"nctId":"NCT04592640","phase":"EARLY_PHASE1","title":"Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2018-09-17","conditions":"Chronic Kidney Diseases, Calciphylaxis, Calcific Uremic Arteriolopathy","enrollment":9},{"nctId":"NCT07449364","phase":"NA","title":"Allogeneic Human Mesenchymal Stem Cell Infusion for Frailty Patient","status":"COMPLETED","sponsor":"Daewoong Group Indonesia","startDate":"2025-03-24","conditions":"Frailty in Older Adults","enrollment":10},{"nctId":"NCT06654193","phase":"PHASE1, PHASE2","title":"Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury","status":"RECRUITING","sponsor":"Hope Biosciences LLC","startDate":"2026-02-01","conditions":"Acute Kidney Injury","enrollment":70},{"nctId":"NCT07431645","phase":"PHASE1","title":"Pilot Study of Radiation-Induced Xerostomia Treatment With Allogeneic Mesenchymal Stromal Stem Cells","status":"COMPLETED","sponsor":"Institute of Oncology Ljubljana","startDate":"2023-04-01","conditions":"Radiation-Induced Xerostomia, Head and Neck Cancer","enrollment":10},{"nctId":"NCT07441720","phase":"PHASE2","title":"Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT)","status":"RECRUITING","sponsor":"Zhejiang Cancer Hospital","startDate":"2026-02-28","conditions":"Thrombocytopenia, Cancer Treatment-induced Thrombocytopenia","enrollment":25},{"nctId":"NCT07439848","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cells (MSCs) and Conditioned Medium Mesenchymal Stem Cells as Adjuvant Therapy for Sepsis","status":"RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2023-12-25","conditions":"Acute Respiratory Distress Syndrome","enrollment":15},{"nctId":"NCT07441226","phase":"PHASE2","title":"Umbilical Cord Mesenchymal Stem Cells as Adjuvant Therapy in Group E COPD Patients","status":"RECRUITING","sponsor":"RSUP Persahabatan","startDate":"2025-08-08","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":20},{"nctId":"NCT07434115","phase":"EARLY_PHASE1","title":"Orthobiological Therapies in Musculoskeletal Disorders","status":"NOT_YET_RECRUITING","sponsor":"PROREGEN","startDate":"2026-01-30","conditions":"Musculoskeletal Diseases or Conditions","enrollment":300},{"nctId":"NCT04314687","phase":"PHASE1, PHASE2","title":"Stem Cell and Conditioned Medium for Cerebral Palsy","status":"ACTIVE_NOT_RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2021-10-13","conditions":"Cerebral Palsy","enrollment":78},{"nctId":"NCT05008588","phase":"PHASE1, PHASE2","title":"Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke Infarct","status":"ACTIVE_NOT_RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2022-05-30","conditions":"Ischemic Stroke","enrollment":15},{"nctId":"NCT05279768","phase":"PHASE1, PHASE2","title":"Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.","status":"COMPLETED","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2022-09-01","conditions":"Polycystic Ovary Syndrome","enrollment":44},{"nctId":"NCT04314661","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cell Therapy (MSCs) and Conditioned Medium Therapy for Osteoartrithis","status":"COMPLETED","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2020-08-03","conditions":"Osteoarthritis, Knee","enrollment":31},{"nctId":"NCT04357600","phase":"PHASE1, PHASE2","title":"Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B","status":"ENROLLING_BY_INVITATION","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2018-05-17","conditions":"Liver Cirrhoses","enrollment":12},{"nctId":"NCT05786287","phase":"","title":"Long-term Safety of UC-MSC Transplantation in Patients With Retinitis Pigmentosa","status":"NOT_YET_RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2026-05","conditions":"Retinitis Pigmentosa","enrollment":18},{"nctId":"NCT05909488","phase":"PHASE2, PHASE3","title":"Role of UC-MSC and CM to Inhibit Vision Loss in Retinitis Pigmentosa Phase I/II","status":"NOT_YET_RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2026-05","conditions":"Retinitis Pigmentosa","enrollment":30},{"nctId":"NCT03158896","phase":"PHASE1","title":"Evaluation of Umbilical Cord-Derived Wharton's Jelly Stem Cells for the Treatment of Acute Graft Versus Host Disease","status":"COMPLETED","sponsor":"University of Kansas Medical Center","startDate":"2018-07-09","conditions":"Acute Graft Versus Host Disease","enrollment":24},{"nctId":"NCT07429253","phase":"PHASE1, PHASE2","title":"Secretome vs. PRP Injections for Hair Density and Growth in Androgenetic Alopecia Patients","status":"RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2026-01-09","conditions":"Androgenetic Alopecia","enrollment":40},{"nctId":"NCT07431008","phase":"","title":"Safety Follow-up Study of Cellgram-ED in Post-Radical Prostatectomy Erectile Dysfunction","status":"RECRUITING","sponsor":"Pharmicell Co., Ltd.","startDate":"2024-12-26","conditions":"Erectile Dysfunction","enrollment":32},{"nctId":"NCT05354141","phase":"PHASE3","title":"Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)","status":"RECRUITING","sponsor":"Direct Biologics, LLC","startDate":"2022-07-01","conditions":"Acute Respiratory Distress Syndrome, ARDS","enrollment":970},{"nctId":"NCT06918808","phase":"PHASE2","title":"DB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn's Disease","status":"RECRUITING","sponsor":"Direct Biologics, LLC","startDate":"2025-05-19","conditions":"Perianal Fistula Due to Crohn's Disease","enrollment":36},{"nctId":"NCT07416578","phase":"NA","title":"Clinical Study on the Effect of Umbilical Cord Mesenchymal Stem Cell Exosomes on Endometrial Repair of Intrauterine Adhesions","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2026-01-01","conditions":"Intrauterine Adhesions, Exosomes","enrollment":60},{"nctId":"NCT07077746","phase":"PHASE2","title":"HB-adMSCs for the Treatment of Crohn's Disease","status":"RECRUITING","sponsor":"Hope Biosciences Research Foundation","startDate":"2026-03","conditions":"Crohn Disease (CD)","enrollment":46},{"nctId":"NCT07413549","phase":"PHASE1, PHASE2","title":"Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Injection in Patients With Decompensated Hepatitis B Cirrhosis","status":"RECRUITING","sponsor":"Beijing Tuohua Weiye Biotechnology Co., Ltd.","startDate":"2025-02-25","conditions":"Decompensated Hepatitis B Cirrhosis","enrollment":76},{"nctId":"NCT07413978","phase":"PHASE1, PHASE2","title":"A Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Severe Acute Respiratory Distress Syndrome","status":"RECRUITING","sponsor":"Changchun Tuohua Pharmaceutical Co., Ltd.","startDate":"2025-04-25","conditions":"Acute Respiratory Distress Syndrome","enrollment":36},{"nctId":"NCT07409259","phase":"EARLY_PHASE1","title":"PT-MSCs Exosome Injection in the Treatment of Chronic-to-acute Liver Failure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2026-01-01","conditions":"Acute-on-Chronic Liver Failure (ACLF)","enrollment":20},{"nctId":"NCT07377838","phase":"PHASE3","title":"Study of ADSTEM Injection for Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis","status":"NOT_YET_RECRUITING","sponsor":"EHL Bio Co., Ltd.","startDate":"2026-06","conditions":"Atopic Dermatitis","enrollment":286},{"nctId":"NCT05697718","phase":"PHASE1","title":"Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cells (IxCell hUC-MSC-S) in the Treatment of Ischemic Stroke","status":"COMPLETED","sponsor":"Shanghai IxCell Biotechnology Co., LTD","startDate":"2023-04-10","conditions":"Ischemic Stroke","enrollment":18},{"nctId":"NCT07299123","phase":"PHASE1, PHASE2","title":"Phase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of SAA","status":"ENROLLING_BY_INVITATION","sponsor":"Chinese PLA General Hospital","startDate":"2023-08-01","conditions":"Severe Aplastic Anemia (SAA), Severe Aplastic Anemia, Refractory, Severe Aplastic Anemia","enrollment":40},{"nctId":"NCT07212335","phase":"EARLY_PHASE1","title":"Safety and Efficacy of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in the Treatment of Long-Term Cytopenia After CAR-T Therapy","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2025-10-01","conditions":"Immune Effector Cell Associated Hematotoxicity","enrollment":15},{"nctId":"NCT07400328","phase":"PHASE2","title":"Amimestrocel Injection for Preventing Severe Oral Mucositis in HSCT Patients","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2026-01-15","conditions":"Oral Mucositis, Stomatitis, Gastrointestinal Mucositis","enrollment":22},{"nctId":"NCT06949137","phase":"PHASE1","title":"Intravenous Infusion of Human Mesenchymal Stem Cells (HMM910 ) in Postmenopausal Women With Osteoporosis at High Risk of Fracture","status":"ACTIVE_NOT_RECRUITING","sponsor":"Help Therapeutics","startDate":"2025-06-20","conditions":"Osteoporosis in Post-menopausal Women, Osteoporosis","enrollment":9},{"nctId":"NCT07396155","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial","status":"RECRUITING","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2026-07-01","conditions":"Diabetic Nephropathy Type 2","enrollment":10},{"nctId":"NCT04594850","phase":"PHASE2","title":"Clinical Trial to Evaluate Efficacy and Safety of of Autologous Mesenchymal Stem Cells (MSC) Injected Intracavernously","status":"COMPLETED","sponsor":"Pharmicell Co., Ltd.","startDate":"2020-10-19","conditions":"Erectile Dysfunction","enrollment":54},{"nctId":"NCT01652209","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of Hearticelgram®-AMI in Patients With Acute Myocardial Infarction.","status":"COMPLETED","sponsor":"Pharmicell Co., Ltd.","startDate":"2013-09-01","conditions":"Acute Myocardial Infarction","enrollment":90},{"nctId":"NCT05820711","phase":"PHASE1","title":"Study Transplanting Bone Marrow Cells Into Salivary Glands to Treat Dry Mouth Caused by Radiation Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2023-07-17","conditions":"Head and Neck Cancer, Xerostomia","enrollment":23},{"nctId":"NCT07295067","phase":"PHASE1","title":"Extracellular Vesicles for the Treatment of Syringomyelia","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2025-12-23","conditions":"Syringomyelia","enrollment":18},{"nctId":"NCT07304440","phase":"PHASE1, PHASE2","title":"Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study","status":"RECRUITING","sponsor":"Adia Med of Winter Park LLC","startDate":"2026-01-12","conditions":"Autism Spectrum Disorder, Autism, ASD","enrollment":100},{"nctId":"NCT06840275","phase":"PHASE2","title":"ASCs in Recently Diagnosed Non-ischemic Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"Cell to Cure ApS","startDate":"2026-03-01","conditions":"Non-Ischemic Heart Failure, Reduced Ejection Fraction Heart Failure","enrollment":90},{"nctId":"NCT02633163","phase":"PHASE2","title":"Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE)","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2018-11-18","conditions":"Systemic Lupus Erythematosus","enrollment":81},{"nctId":"NCT05553132","phase":"PHASE1","title":"A Study of REcycled CartiLage Auto/Allo IMplantation to Treat and Repair Focal Hip Cartilage Defects","status":"ACTIVE_NOT_RECRUITING","sponsor":"Daniel B. F. Saris","startDate":"2023-08-08","conditions":"Cartilage Defect","enrollment":15},{"nctId":"NCT05095532","phase":"PHASE1","title":"Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2021-12-01","conditions":"Chronic Pancreatitis, Mesenchymal Stem Cells","enrollment":42},{"nctId":"NCT06775964","phase":"PHASE1, PHASE2","title":"Stem Cell Therapy for Early Alzheimer's Disease","status":"RECRUITING","sponsor":"Paul E Schulz","startDate":"2026-02","conditions":"Cognitive Dysfunction","enrollment":12},{"nctId":"NCT07379528","phase":"","title":"Mesenchymal Stem Cells in NPM1 Mutated Low Risk Acute Myeloid Leukemia: a Study of the Tumor Microenvironment and Its Contribution to the Outcome","status":"COMPLETED","sponsor":"Fondazione IRCCS Policlinico San Matteo di Pavia","startDate":"2023-03-15","conditions":"Acute Myeloid Leukaemia (AML)","enrollment":70},{"nctId":"NCT07373054","phase":"NA","title":"Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Androgenic Alopecia","status":"RECRUITING","sponsor":"Fujian Medical University Union Hospital","startDate":"2025-11-06","conditions":"Androgenic Alopecia","enrollment":18},{"nctId":"NCT01733186","phase":"PHASE1, PHASE2","title":"Evaluation of Safety and Exploratory Efficacy of CARTISTEM®, a Cell Therapy Product for Articular Cartilage Defects","status":"COMPLETED","sponsor":"Medipost, Inc.","startDate":"2013-01-07","conditions":"Degeneration Articular Cartilage Knee","enrollment":12},{"nctId":"NCT06919081","phase":"PHASE2","title":"Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease","status":"RECRUITING","sponsor":"University of Illinois at Chicago","startDate":"2025-08-01","conditions":"Persistent Corneal Epithelial Defect, Corneal Epithelial Disorders","enrollment":24},{"nctId":"NCT07374679","phase":"","title":"Long-Term Follow-up Study to Evaluate Long-Term Safety and Efficacy of Allogenic Umbilical Cord-derived Mesenchymal Stem Cell in Patients With Rotator Cuff Disease","status":"NOT_YET_RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2026-01-26","conditions":"Rotator Cuff Disease","enrollment":21},{"nctId":"NCT03325322","phase":"PHASE2","title":"Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease","status":"SUSPENDED","sponsor":"Mayo Clinic","startDate":"2018-01-02","conditions":"Chronic Kidney Diseases, Diabetes Mellitus, Diabetic Nephropathies","enrollment":30},{"nctId":"NCT06752577","phase":"","title":"Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2024-12-22","conditions":"Chronic Kidney Diseases, Kidney Transplant","enrollment":75},{"nctId":"NCT06075706","phase":"PHASE2","title":"Trial of Efficacy and Safety of MC0518 Versus Best Available Therapy in Participants With Steroid-Refractory Acute Graft Versus Host Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"medac GmbH","startDate":"2023-11-13","conditions":"Steroid-refractory Acute Graft-versus-host Disease","enrollment":48},{"nctId":"NCT02677350","phase":"PHASE1","title":"AlloGeneic Human Mesenchymal Stem Cells (hMSC) in PAtients With FistuLizing Crohn's Disease Via PErifistula iNjEctions (GALENE)","status":"WITHDRAWN","sponsor":"Joshua M Hare","startDate":"2019-12-01","conditions":"Crohn's Disease, Fistulizing Crohn's Disease, Stem Cells","enrollment":""},{"nctId":"NCT07367815","phase":"PHASE1, PHASE2","title":"Allogeneic Adipose Tissue Derived-stem Cells in Alzheimer Disease","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2026-03-01","conditions":"Alzheimer Disease","enrollment":9},{"nctId":"NCT06677931","phase":"NA","title":"Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Melasma","status":"COMPLETED","sponsor":"Fujian Medical University Union Hospital","startDate":"2024-08-28","conditions":"Melasma","enrollment":30},{"nctId":"NCT05331872","phase":"PHASE1","title":"Umbilical Cord-derived Mesenchymal Stem Cell Infusion in the Management of Adult Liver Cirrhosis","status":"COMPLETED","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2021-01-01","conditions":"Liver Cirrhosis","enrollment":20},{"nctId":"NCT07143812","phase":"PHASE1","title":"A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma","status":"RECRUITING","sponsor":"CHA University","startDate":"2025-10-23","conditions":"Glioblastoma (GBM), Newly Diagnosed Glioblastoma Multiforme","enrollment":10},{"nctId":"NCT06726538","phase":"PHASE1, PHASE2","title":"Investigating the Efficacy of Autologous, Adipose-derived Mesenchymal Stem Cell Therapy for the Treatment of Sexual Function Impairment in Women Aged 40-50","status":"COMPLETED","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2023-10-01","conditions":"Female Sexual Dysfunction","enrollment":50},{"nctId":"NCT04312113","phase":"PHASE1","title":"Angiographic Delivery of AD-MSC for Ulcerative Colitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2020-11-16","conditions":"Ulcerative Colitis","enrollment":20},{"nctId":"NCT04652908","phase":"PHASE1, PHASE2","title":"Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial","status":"RECRUITING","sponsor":"University of California, Davis","startDate":"2021-06-21","conditions":"Myelomeningocele","enrollment":55},{"nctId":"NCT04063215","phase":"PHASE1, PHASE2","title":"A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy","status":"COMPLETED","sponsor":"Hope Biosciences LLC","startDate":"2020-01-01","conditions":"Traumatic Brain Injury","enrollment":24},{"nctId":"NCT07344324","phase":"NA","title":"Study Evaluating the Safety and Feasibility of Endoscopic Duodenal Injections of Autologous Mesenchymal Stem Cells","status":"NOT_YET_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2026-02-02","conditions":"Diabete Type 2, Insulin Resistant Diabetes (Mellitus), Obesity","enrollment":15},{"nctId":"NCT07338877","phase":"","title":"RenewDisc Trial: Endoscopic Discectomy and Autologous Stem Cell Therapy for Discogenic Low Back Pain","status":"ENROLLING_BY_INVITATION","sponsor":"EPC Education s.r.o.","startDate":"2024-10-01","conditions":"Discogenic Low Back Pain, Intervertebral Disc Degeneration, Lumbar Disc Disease","enrollment":120}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"BRONCHITIS"},{"count":1,"reaction":"DRUG INEFFECTIVE FOR UNAPPROVED INDICATION"},{"count":1,"reaction":"GAIT DISTURBANCE"},{"count":1,"reaction":"ILLNESS"},{"count":1,"reaction":"JOINT SWELLING"},{"count":1,"reaction":"PAIN IN EXTREMITY"},{"count":1,"reaction":"PERIPHERAL SWELLING"},{"count":1,"reaction":"RESPIRATORY FAILURE"},{"count":1,"reaction":"SQUAMOUS CELL CARCINOMA"},{"count":1,"reaction":"WRONG TECHNIQUE IN PRODUCT USAGE PROCESS"}],"_approvalHistory":[],"publicationCount":67507,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Autologous MSC","MSC","MSCs","mesenchymal stomal cells","Mscs"],"phase":"phase_3","status":"active","brandName":"Mesenchymal Stem Cells","genericName":"Mesenchymal Stem Cells","companyName":"Ottawa Hospital Research Institute","companyId":"ottawa-hospital-research-institute","modality":"Biologic","firstApprovalDate":"","aiSummary":"Mesenchymal stem cells promote tissue repair and modulate immune responses through secretion of anti-inflammatory factors and differentiation into specialized cell types. Used for Graft-versus-host disease (GVHD), Tissue repair and regeneration, Inflammatory conditions.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":8,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}